首页> 中文期刊> 《亚太热带医药杂志(英文版)》 >SARS-CoV-2 variants:A continuing threat to global health

SARS-CoV-2 variants:A continuing threat to global health

         

摘要

Coronavirus disease 2019(COVID-19)is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).COVID-19 pandemic has an unprecedented impact on economy,trade and human lifestyle globally.Since the emergence of of SARS-CoV-2,more than 266 million infections and 5260888 deaths were reported globally over the last two years[1].The scientific achievements particularly in last two years yielded effective vaccines against COVID-19.A variety of platform technologies including protein subunit,viral vector,RNA,inactivated and DNA are being employed to develop effective vaccines.To date,vaccines that have been approved against COVID-19 include the Pfizer BioNTech(mRNA vaccine),Oxford-AstraZeneca(viral vector vaccine),Moderna(mRNA vaccine),Janssen Ad26.COV2.S(viral vector),Sinopharm,Sinovac-CoronaVac,Bharat Biotech’s Covaxin(inactivated virus vaccines),etc.As of December 2021,over 8 billion doses of COVID-19 vaccines have been administered globally[1].The details on the number of COVID-19 confirmed cases and global vaccination coverage are provided in Figure 1.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号